JP2024542188A5 - - Google Patents
Info
- Publication number
- JP2024542188A5 JP2024542188A5 JP2024529348A JP2024529348A JP2024542188A5 JP 2024542188 A5 JP2024542188 A5 JP 2024542188A5 JP 2024529348 A JP2024529348 A JP 2024529348A JP 2024529348 A JP2024529348 A JP 2024529348A JP 2024542188 A5 JP2024542188 A5 JP 2024542188A5
- Authority
- JP
- Japan
- Prior art keywords
- branched
- independently
- alkyl
- compound according
- unbranched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163264149P | 2021-11-16 | 2021-11-16 | |
| US63/264,149 | 2021-11-16 | ||
| PCT/US2022/050111 WO2023091490A1 (en) | 2021-11-16 | 2022-11-16 | Novel ionizable lipids and lipid nanoparticles and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024542188A JP2024542188A (ja) | 2024-11-13 |
| JP2024542188A5 true JP2024542188A5 (cg-RX-API-DMAC7.html) | 2025-11-18 |
Family
ID=84537194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529348A Pending JP2024542188A (ja) | 2021-11-16 | 2022-11-16 | 新規イオン化可能な脂質および脂質ナノ粒子ならびにそれらを使用する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250049948A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4433450A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024542188A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240122774A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118829625A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022394985A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3238292A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024005970A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023091490A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108368028B (zh) | 2015-10-28 | 2021-09-03 | 爱康泰生治疗公司 | 用于递送核酸的新型脂质和脂质纳米颗粒制剂 |
| US12678515B2 (en) | 2015-12-30 | 2026-07-14 | Acuitas Therapeutics, Inc. | Lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| US12491261B2 (en) | 2016-10-26 | 2025-12-09 | Acuitas Therapeutics, Inc. | Lipid nanoparticle formulations |
| CA3116576A1 (en) | 2018-10-18 | 2020-04-23 | Acuitas Therapeutics, Inc. | Lipids for lipid nanoparticle delivery of active agents |
| KR20230051172A (ko) | 2020-07-16 | 2023-04-17 | 아퀴타스 테라퓨틱스 인크. | 지질 나노 입자에 사용하기 위한 양이온성 지질 |
| EP4719352A1 (en) | 2023-05-31 | 2026-04-08 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| JP2026521725A (ja) * | 2023-06-16 | 2026-07-01 | アクイタス セラピューティクス インコーポレイテッド | アミド含有脂質 |
| CN117185942B (zh) * | 2023-07-04 | 2025-09-12 | 清华大学 | 一种可用于靶向肺部递送广谱中和抗体的脂质纳米颗粒及其制备方法与应用 |
| WO2025042786A1 (en) | 2023-08-18 | 2025-02-27 | Flagship Pioneering Innovations Vi, Llc | Compositions comprising circular polyribonucleotides and uses thereof |
| TW202541819A (zh) | 2023-12-27 | 2025-11-01 | 日商安斯泰來製藥股份有限公司 | 脊髓損傷之治療用醫藥組成物及脊髓損傷之非人類靈長類動物模式之製作方法 |
| US20250381150A1 (en) | 2024-03-08 | 2025-12-18 | Genzyme Corporation | Lipid nanoparticles |
| WO2026029046A1 (ja) * | 2024-07-30 | 2026-02-05 | アステラス製薬株式会社 | 側鎖に環状基を有するウレア又はカーバメート脂質、その脂質ナノ粒子、及びその医薬組成物 |
| WO2026030375A2 (en) | 2024-07-30 | 2026-02-05 | Genzyme Corporation | Lipid nanoparticles and methods of manufacture and use thereof |
| WO2026109749A1 (en) * | 2024-11-24 | 2026-05-28 | Neovac Ltd. | Ionizable lipids suitable for nucleic acid delivery |
| WO2026142951A1 (en) | 2024-12-23 | 2026-07-02 | Genzyme Corporation | Pharmaceutical system |
| WO2026152164A1 (en) | 2025-01-13 | 2026-07-16 | Sail Biomedicines, Inc. | Cd5-targeted lipid nanoparticles encapsulating polyribonucleotides encoding chimeric antigen receptors, and methods to generate car-expressing t cells in vivo |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0079963B1 (en) | 1981-06-04 | 1986-08-27 | Delaware Chemicals Corporation | Pressurized container with dispensing pump |
| US4778810A (en) | 1987-01-08 | 1988-10-18 | Nastech Pharmaceutical Co., Inc. | Nasal delivery of caffeine |
| US6197553B1 (en) | 1994-07-15 | 2001-03-06 | Merck & Co., Inc. | Method for large scale plasmid purification |
| US5965542A (en) | 1997-03-18 | 1999-10-12 | Inex Pharmaceuticals Corp. | Use of temperature to control the size of cationic liposome/plasmid DNA complexes |
| US6410328B1 (en) | 1998-02-03 | 2002-06-25 | Protiva Biotherapeutics Inc. | Sensitizing cells to compounds using lipid-mediated gene and compound delivery |
| JP2002502831A (ja) | 1998-02-03 | 2002-01-29 | イネックス ファーマシューティカルズ コーポレイション | 癌の治療に用いる血清に対して安定なプラスミド脂質粒子の全身供与 |
| US6211140B1 (en) | 1999-07-26 | 2001-04-03 | The Procter & Gamble Company | Cationic charge boosting systems |
| EP1519714B1 (en) | 2002-06-28 | 2010-10-20 | Protiva Biotherapeutics Inc. | Method and apparatus for producing liposomes |
| AU2004257373B2 (en) | 2003-07-16 | 2011-03-24 | Arbutus Biopharma Corporation | Lipid encapsulated interfering RNA |
| US6927663B2 (en) | 2003-07-23 | 2005-08-09 | Cardiac Pacemakers, Inc. | Flyback transformer wire attach method to printed circuit board |
| CN1882693B (zh) | 2003-09-15 | 2012-08-15 | 普洛体维生物治疗公司 | 聚乙二醇修饰的脂质化合物及其应用 |
| CA2569664C (en) | 2004-06-07 | 2013-07-16 | Protiva Biotherapeutics, Inc. | Lipid encapsulated interfering rna |
| US7745651B2 (en) | 2004-06-07 | 2010-06-29 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods of use |
| JP5639338B2 (ja) | 2005-07-27 | 2014-12-10 | プロチバ バイオセラピューティクス インコーポレイティッド | リポソームの製造システムおよび製造方法 |
| EP3100718B1 (en) | 2008-01-02 | 2019-11-27 | Arbutus Biopharma Corporation | Improved compositions and methods for the delivery of nucleic acids |
| EP2279254B1 (en) | 2008-04-15 | 2017-07-05 | Protiva Biotherapeutics Inc. | Novel lipid formulations for nucleic acid delivery |
| EP3699172A3 (en) | 2008-11-10 | 2020-11-18 | Arbutus Biopharma Corporation | Novel lipids and compositions for the delivery of therapeutics |
| ES2613498T3 (es) | 2009-07-01 | 2017-05-24 | Protiva Biotherapeutics Inc. | Nuevas formulaciones de lípidos para el suministro de agentes terapéuticos a tumores sólidos |
| US8569256B2 (en) | 2009-07-01 | 2013-10-29 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods for the delivery of therapeutic agents |
| WO2011066651A1 (en) | 2009-12-01 | 2011-06-09 | Protiva Biotherapeutics, Inc. | Snalp formulations containing antioxidants |
| CA3044884A1 (en) | 2009-12-07 | 2011-06-16 | Arbutus Biopharma Corporation | Compositions for nucleic acid delivery |
| US20130017223A1 (en) | 2009-12-18 | 2013-01-17 | The University Of British Columbia | Methods and compositions for delivery of nucleic acids |
| US20130123338A1 (en) | 2010-05-12 | 2013-05-16 | Protiva Biotherapeutics, Inc. | Novel cationic lipids and methods of use thereof |
| EP4481047A3 (en) | 2010-06-03 | 2025-04-16 | Alnylam Pharmaceuticals, Inc. | Biodegradable lipids for the delivery of active agents |
| WO2012016184A2 (en) | 2010-07-30 | 2012-02-02 | Alnylam Pharmaceuticals, Inc. | Methods and compositions for delivery of active agents |
| US8466122B2 (en) | 2010-09-17 | 2013-06-18 | Protiva Biotherapeutics, Inc. | Trialkyl cationic lipids and methods of use thereof |
| US9999673B2 (en) | 2011-01-11 | 2018-06-19 | Alnylam Pharmaceuticals, Inc. | PEGylated lipids and their use for drug delivery |
| CA2831613A1 (en) | 2011-03-31 | 2012-10-04 | Moderna Therapeutics, Inc. | Delivery and formulation of engineered nucleic acids |
| US8691750B2 (en) | 2011-05-17 | 2014-04-08 | Axolabs Gmbh | Lipids and compositions for intracellular delivery of biologically active compounds |
| WO2013016058A1 (en) | 2011-07-22 | 2013-01-31 | Merck Sharp & Dohme Corp. | Novel bis-nitrogen containing cationic lipids for oligonucleotide delivery |
| JP6250543B2 (ja) | 2011-09-27 | 2017-12-20 | アルニラム・ファーマシューティカルズ・インコーポレーテッド | ジ脂肪族置換peg化脂質 |
| US8762704B2 (en) | 2011-09-29 | 2014-06-24 | Apple Inc. | Customized content for electronic devices |
| WO2013086322A1 (en) | 2011-12-07 | 2013-06-13 | Alnylam Pharmaceuticals, Inc. | Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agents |
| US20140308304A1 (en) | 2011-12-07 | 2014-10-16 | Alnylam Pharmaceuticals, Inc. | Lipids for the delivery of active agents |
| DE21212055T1 (de) | 2011-12-07 | 2022-08-04 | Alnylam Pharmaceuticals, Inc. | Biologisch abbaubare lipide zur freisetzung von wirkstoffen |
| ES2923757T3 (es) | 2011-12-16 | 2022-09-30 | Modernatx Inc | Composiciones de ARNm modificado |
| US9415109B2 (en) | 2012-07-06 | 2016-08-16 | Alnylam Pharmaceuticals, Inc. | Stable non-aggregating nucleic acid lipid particle formulations |
| CA2953341C (en) | 2014-06-25 | 2023-01-24 | Acuitas Therapeutics Inc. | Lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| HUE067372T2 (hu) | 2015-06-29 | 2024-10-28 | Acuitas Therapeutics Inc | Lipidek és nanoszemcsés lipid formulázások nukleinsavak beadására |
| CN108368028B (zh) | 2015-10-28 | 2021-09-03 | 爱康泰生治疗公司 | 用于递送核酸的新型脂质和脂质纳米颗粒制剂 |
| US12678515B2 (en) | 2015-12-30 | 2026-07-14 | Acuitas Therapeutics, Inc. | Lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| WO2019089828A1 (en) * | 2017-10-31 | 2019-05-09 | Acuitas Therapeutics, Inc. | Lamellar lipid nanoparticles |
| CN113939282A (zh) | 2019-01-31 | 2022-01-14 | 摩登纳特斯有限公司 | 制备脂质纳米颗粒的方法 |
| CA3204244A1 (en) * | 2021-01-06 | 2022-07-14 | Lorena Lerner | Encapsulated rna polynucleotides and methods of use |
| TWI918825B (zh) * | 2021-02-10 | 2026-03-21 | 美商艾勒維生技公司 | 化合物、組合物及其使用方法 |
-
2022
- 2022-11-16 US US18/710,109 patent/US20250049948A1/en active Pending
- 2022-11-16 JP JP2024529348A patent/JP2024542188A/ja active Pending
- 2022-11-16 EP EP22826269.7A patent/EP4433450A1/en active Pending
- 2022-11-16 AU AU2022394985A patent/AU2022394985A1/en active Pending
- 2022-11-16 WO PCT/US2022/050111 patent/WO2023091490A1/en not_active Ceased
- 2022-11-16 CN CN202280088355.3A patent/CN118829625A/zh active Pending
- 2022-11-16 MX MX2024005970A patent/MX2024005970A/es unknown
- 2022-11-16 KR KR1020247019980A patent/KR20240122774A/ko active Pending
- 2022-11-16 CA CA3238292A patent/CA3238292A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024542260A5 (cg-RX-API-DMAC7.html) | ||
| JP2022505234A5 (cg-RX-API-DMAC7.html) | ||
| TWI699354B (zh) | 陽離子性脂質 | |
| JP2024546951A5 (cg-RX-API-DMAC7.html) | ||
| JP2023164871A5 (cg-RX-API-DMAC7.html) | ||
| ES2521672T3 (es) | Formulaciones farmacéuticas para el tratamiento del cáncer | |
| ES2926075T3 (es) | Lípido catiónico | |
| JP2024542188A (ja) | 新規イオン化可能な脂質および脂質ナノ粒子ならびにそれらを使用する方法 | |
| PE20210655A1 (es) | Carbamoil ciclohexil acidos ligados a n de triazol como antagonistas de lpa | |
| JP2025510229A5 (cg-RX-API-DMAC7.html) | ||
| JP2007501185A5 (cg-RX-API-DMAC7.html) | ||
| JP2013531634A (ja) | オリゴヌクレオチド送達のための新規なアミノアルコールカチオン性脂質 | |
| JP2018524339A5 (cg-RX-API-DMAC7.html) | ||
| JP2022533069A5 (cg-RX-API-DMAC7.html) | ||
| JP2008508214A (ja) | 女性の性障害の治療用ピペラジン誘導体 | |
| JP2009114205A (ja) | 心臓血管系および中枢神経系の特定疾病を治療するための縮合(ヘタリール置換)1−ベンジル−3−ピラゾール誘導体の使用 | |
| JP2003502405A5 (cg-RX-API-DMAC7.html) | ||
| JP2023541427A (ja) | 骨格筋送達プラットフォーム及び使用方法 | |
| JP2023538524A5 (cg-RX-API-DMAC7.html) | ||
| JP2023518944A5 (cg-RX-API-DMAC7.html) | ||
| RU2319692C2 (ru) | Производные тетрагидрокарбазола, способ получения производных тетрагидрокарбазола (варианты), их применение (варианты) и фармацевтическая композиция, обладающая активностью антагониста гонадотропин-рилизинг-гормона (варианты) | |
| JP2010507722A (ja) | 標的化リガンドを固定化するための改良型リンカー | |
| JP2021165281A (ja) | 特異的炎症収束性メディエーターの塩に関連する組成物及び方法 | |
| JP2024543272A5 (cg-RX-API-DMAC7.html) | ||
| JP2024512770A (ja) | 遺伝子送達における非ウイルスベクターとしての樹状構造 |